Advertisement
Screener

NEURAXIS, INC. (NRXS) Graph

Add as a preferred source on Google

NRXS Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $1.93M; Cost of revenue $272.57K; Research and development $274.34K; Net income -$2.09M.
  • 2026-03-31: Revenue $1.61M; Cost of revenue $218.37K; Research and development $99.57K; Net income -$1.76M.
  • 2025-12-31: Revenue $968.13K*; Cost of revenue $141.65K*; Research and development $146.18K*; Net income -$1.71M*.
  • 2025-09-30: Revenue $811.41K; Cost of revenue $135.49K; Research and development $130.85K; Net income -$2.12M.

Revenue flow

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

NRXS revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Revenue$1.93MCost of revenue$272.57KGross profit$1.66MOperating income-$2.12MOther income, net$38.97KResearch & development$274.34KNet income-$2.09M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentNet income
2026-06-30$1.93M$272.57K$274.34K-$2.09M
2026-03-31$1.61M$218.37K$99.57K-$1.76M
2025-12-31$968.13K*$141.65K*$146.18K*-$1.71M*
2025-09-30$811.41K$135.49K$130.85K-$2.12M
2025-06-30$894.09K$146.64K$115.20K-$1.69M
2025-03-31$895.65K$139.47K$117.87K-$2.28M
2024-09-30$666.63K$97.05K$126.25K-$1.76M
2024-06-30$611.50K$73.46K$54.31K-$2.92M
2024-03-31$646.63K$75.08K$5.57K-$2.12M
2023-09-30$477.46K$67.29K$44.95K-$8.63M
2023-06-30$646.02K$67.81K$109.79K-$2.24M
2023-03-31$805.11K$95.90K$16.80K-$2.17M
2022-09-30$618.80K$67.64K$86.17K-$2.08M
2022-06-30$682.58K$79.01K$13.66K-$1.52M
2022-03-31(m)(m)(m)-$1.17M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentNet income
2026-06-30$3.54M$490.94K$373.91K-$3.85M
2025-06-30$1.79M$286.12K$222.20K-$3.97M
2024-06-30$1.26M$148.54K$59.88K-$5.04M
2023-06-30$1.45M$163.71K$126.59K-$4.41M
2022-06-30$1.45M$154.21K$58.06K-$2.69M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentNet income
2025-09-30$2.60M$421.26K$347.43K-$6.09M
2024-09-30$1.92M$256.95K$295.19K-$6.79M
2023-09-30$1.93M$231.00K$171.54K-$13.03M
2022-09-30$2.07M$221.85K$144.24K-$4.77M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentNet income
2025-12-31$3.57M$562.92K$493.61K-$7.80M
2024-12-31$2.69M$362.00K$433.61K-$8.24M
2023-12-31$2.46M$303.35K$169.31K-$14.63M
2022-12-31$2.68M$297.06K$225.61K-$4.78M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nexalin Technology, Inc. (NXL)United States$0.094B
electroCore, Inc. (ECOR)United States$0.102B
Streamex Corp. (STEX)United States$0.089B-0.19
Vivani Medical, Inc. (VANI)United States$0.111B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
EDAP TMS SA (FOCL)$0.171B
IRIDEX CORP (IRIX)United States$0.011B
Advertisement